BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23993440)

  • 1. Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder.
    Sylvia LG; Friedman ES; Kocsis JH; Bernstein EE; Brody BD; Kinrys G; Kemp DE; Shelton RC; McElroy SL; Bobo WV; Kamali M; McInnis MG; Tohen M; Bowden CL; Ketter TA; Deckersbach T; Calabrese JR; Thase ME; Reilly-Harrington NA; Singh V; Rabideau DJ; Nierenberg AA
    J Affect Disord; 2013 Nov; 151(2):722-727. PubMed ID: 23993440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.
    Suppes T; Kelly DI; Keck PE; McElroy SL; Altshuler LL; Mintz J; Frye MA; Nolen WA; Luckenbaugh DA; Post RM; Leverich GS; Kupka RW; Grunze H
    Int Clin Psychopharmacol; 2007 Nov; 22(6):376-81. PubMed ID: 17917557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.
    Nierenberg AA; Sylvia LG; Leon AC; Reilly-Harrington NA; Shesler LW; McElroy SL; Friedman ES; Thase ME; Shelton RC; Bowden CL; Tohen M; Singh V; Deckersbach T; Ketter TA; Kocsis JH; McInnis MG; Schoenfeld D; Bobo WV; Calabrese JR;
    Clin Trials; 2014 Feb; 11(1):114-27. PubMed ID: 24346608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis.
    Fajutrao L; Paulsson B; Liu S; Locklear J
    Clin Ther; 2009 Jun; 31 Pt 1():1456-68. PubMed ID: 19698903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.
    Deckersbach T; Nierenberg AA; McInnis MG; Salcedo S; Bernstein EE; Kemp DE; Shelton RC; McElroy SL; Sylvia LG; Kocsis JH; Bobo WV; Friedman ES; Singh V; Tohen M; Bowden CL; Ketter TA; Calabrese JR; Thase ME; Reilly-Harrington NA; Rabideau DJ; Kinrys G; Kamali M
    J Clin Psychiatry; 2016 Jan; 77(1):100-8. PubMed ID: 26845265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium.
    Ketter TA; Miller S; Dell'Osso B; Wang PW
    J Affect Disord; 2016 Feb; 191():256-73. PubMed ID: 26688495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression.
    Kim SJ; Lee YJ; Lee YJ; Cho SJ
    J Affect Disord; 2014 Mar; 157():33-40. PubMed ID: 24581825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
    Sylvia LG; Shelton RC; Kemp DE; Bernstein EE; Friedman ES; Brody BD; McElroy SL; Singh V; Tohen M; Bowden CL; Ketter TA; Deckersbach T; Thase ME; Reilly-Harrington NA; Nierenberg AA; Rabideau DJ; Kinrys G; Kocsis JH; Bobo WV; Kamali M; McInnis MG; Calabrese JR
    Bipolar Disord; 2015 Mar; 17(2):212-23. PubMed ID: 25130321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-23 and TGF-β1 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode.
    Li H; Hong W; Zhang C; Wu Z; Wang Z; Yuan C; Li Z; Huang J; Lin Z; Fang Y
    J Affect Disord; 2015 Mar; 174():361-6. PubMed ID: 25545602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mood stabilization in the treatment of bipolar disorder: focus on quetiapine.
    Vieta E
    Hum Psychopharmacol; 2005 Jun; 20(4):225-36. PubMed ID: 15880391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial.
    Sylvia LG; Chang WC; Kamali M; Tohen M; Kinrys G; Deckersbach T; Calabrese JR; Thase ME; Reilly-Harrington N; Bobo WV; Kocsis JH; McInnis MG; Bowden CL; Ketter TA; Friedman ES; Shelton RC; McElroy SL; Gao K; Rabideau DJ; Nierenberg AA
    J Affect Disord; 2018 Jan; 225():563-568. PubMed ID: 28881294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE
    J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale.
    Kinrys G; Bowden CL; Nierenberg AA; Hearing CM; Gold AK; Rabideau DJ; Sylvia LG; Gao K; Kamali M; Bobo WV; Tohen M; Deckersbach T; McElroy SL; Ketter TA; Shelton RC; Friedman ES; Calabrese JR; McInnis MG; Kocsis J; Thase ME; Singh V; Reilly-Harrington NA
    J Affect Disord; 2019 Mar; 246():126-131. PubMed ID: 30580198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spotlight on quetiapine in bipolar depression.
    Keating GM; Robinson DM
    CNS Drugs; 2007; 21(8):695-7. PubMed ID: 17630822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.
    Dando TM; Keating GM
    Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.